Page last updated: 2024-09-03

me 2303 and B16 Melanoma

me 2303 has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sudo, Y; Sugimoto, Y; Takamori, R; Tsuruo, T; Yusa, K	1

Other Studies

1 other study(ies) available for me 2303 and B16 Melanoma

Article	Year
A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Cancer research, 1989, Oct-15, Volume: 49, Issue:20 Topics: Animals; Doxorubicin; Drug Resistance; In Vitro Techniques; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Neoplasms, Experimental; Sarcoma, Experimental; Tumor Cells, Cultured	1989

Article

Year

A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.

Cancer research, 1989, Oct-15, Volume: 49, Issue:20

Topics: Animals; Doxorubicin; Drug Resistance; In Vitro Techniques; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Neoplasms, Experimental; Sarcoma, Experimental; Tumor Cells, Cultured

1989